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Two rat liver cytosol fractions containing activated glucocorticoid-receptor complexes are able to stimulate the tran- 
scriptional activity of rat liver nuclei; the respective fractions from the cytosol of thymocytes inhibit the capacity of thy- 
mus nuclei for RNA synthesis. A similar inhibitory effect on thymus nuclei is exerted by the presence of rat liver cytosol 
fractions. Spot hybridization using a tyrosine aminotransferase (TAT) probe demonstrates that TAT gene expression 
is stimulated by the liver cytosol fractions acting on homologous nuclei whereas it is inhibited, in thymus nuclei, by the 
addition of thymus cytosol fractions. No effect on transcription is observed if the liver or thymus cytosol is heat activated 
in the presence of the glucocorticoid antagonist, cortexolone. Treatment of liver nuclei, previously subjected to the action 
of thymus cytosol fractions with the respective liver ones, restores transcriptional activity to control or higher levels. We 
conclude that rat thymocyte nuclei and cytosol contain transcriptional factors, which in the presence of the glucocorti- 
coid-receptor complex, irrespective of its source, inhibit gene expression, whereas in the absence of such factors, the gluco- 
corticoid-receptor complex positively regulates the respective genes. 
Glucocorticoid receptor; Transcription; (Liver, Thymus, Nucleus) 
1. INTRODUCTION 
The phenotypic expression of glucocorticoid ac- 
tion varies according to the target cell involved. In 
the liver, a major effect is the stimulation of 
gluconeogenesis, involving induction of enzymes, 
such as tyrosine aminotransferase and tryptophan 
oxygenase, whereas in thymus these hormones lead 
to cell lysis and death [1,2]. The molecular basis 
for the differential response of target cells to the 
same hormone represents a central problem of cur- 
rent interest. Glucocorticoids exert their biological 
effects on target cells by binding with high affinity 
and specificity to a soluble receptor protein. This 
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interaction triggers a structural change in the 
receptor molecule, resulting in the ability to 
recognize and to bind to transcriptional enhancer 
DNA elements of hormone-dependent genes, 
positively or negatively controlled by the hormone 
(review [I 11). The fact that glucocorticoid recep- 
tors from rat liver and thymus display the same 
physico-chemical and, immunological character- 
istics and have equal molecular masses [5,6], 
together with the recent finding that one copy of 
the glucocorticoid gene is present per haploid gene 
[3,4] constitute evidence in favour of the existence 
of solely a single glucorticoid receptor in all target 
cells. Recent findings demonstrating that glucocor- 
ticoid receptors exert their transcriptional control 
by cooperating with other trans-acting factors 
(NF-1, CACC, CAAT) [7] suggest hat the target 
gene specificity of glucocorticoids is determined 
not solely by the receptor protein but also through 
its cooperation with other transcription factors. 
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We have previously shown that isolated nuclei 
possess the ability to respond to addition of 
homologous cytosol fractions containing activated 
glucocorticoid-receptor complexes with increased 
(liver) or decreased (thymus) rates of RNA syn- 
thesis [8]. To explore the mechanism underlying 
the tissue specificity of glucocorticoids, we 
monitored the response of nuclear fractions to the 
presence of heterologous cytosol fractions. 
2. EXPERIMENTAL 
Cytosol and nuclei from rat liver and thymus were prepared 
from male Wistar rats (6-8 weeks old) that were adrenalec- 
tomized 6-7 days before being killed. 
Fractionation of heat-activated cytosol labelled with [“Hldex- 
amethasone from rat liver or thymus through DEAE-A50 was 
performed as described 181. Two fractions containing 
[3H]dexamethasone-receptor complexes were obtained, one in 
the flow-through (DE-l) and the other eluting from the column 
at 150 mM Cl- (DE-2). With the exception of heat activation all 
other steps were performed at 0-4°C. 
Translocation of the [‘Hldexamethasone-receptor c mplex to 
the nucleus was monitored by assaying ‘H activity in aliquots 
of the nuclei, washed three times with buffer. Assuming that 
1 mol hormone binds per mol receptor, the amount (in pmol) 
of receptor translocated could be determined. 
The capacity for RNA synthesis of treated nuclei was 
evaluated in a standard reaction mixture containing the four 
nucleoside triphosphates one of which (UTP) was ‘H-labelled. 
For dot-hybridization assays, UTP was labelled with ‘*P 
(200 yCi per assay). The ion composition was 4.4 mM MgClz, 
2.24 mM MnCl2, 80 mM KCI, 6 mM NaF. 
For dot-hybridization [‘*P]RNA was hybridized to 6pg 
linearized TAT cDNA containing the genomic fragments of 
2.45, 1.05 and 0.9 kb, immobilized on nitrocellulose filters. For 
measuring non-specific hybridization, hybridization with 
pBR322 DNA was performed for each point. 
3. RESULTS AND DISCUSSION 
TO explore the possibility that the differential 
action of glucocorticoids on various target cells, 
i.e. positive transcriptional control on hepatocytes 
and negative on thymocytes, is exerted through the 
interaction of the glucocorticoid receptor with 
transcriptional factors, we followed the effects of 
liver or thymus cytosol fractions containing ac- 
tivated dexamethasone-receptor complexes, on 
transcription of isolated heterologous nuclei. On 
submitting cytosol to DEAE-Sephadex A-50 col- 
umn chromatography, two fractions (DE-l and 
DE-2), as described in [8], were isolated and shown 
by DNA-binding experiments (not shown) to con- 
tain activated dexamethasone-receptor complexes. 
The hormone-receptor complex contained in these 
fractions can: (i) translocate to nuclei, in a time- 
dependent fashion (table 1); (ii) saturate the 
nuclear acceptor sites (table 1); and (iii) modulate 
the capacity for RNA synthesis of nuclei (see 
below). As reported previously 181, rat liver nuclei 
respond with increased RNA synthesis to the addi- 
tion of homologous cytosol fractions, whereas 
thymus nuclear transcription is inhibited by the 
homologous cytosol fractions. It should be noted 
that most of the RNA synthesis activity of the 
nuclear system is due to elongation and not initia- 
tion of transcription, as demonstrated by use of 
the rifampicin derivatives, AF05 and AF013; fur- 
thermore, it should be borne in mind that all three 
DNA-dependent RNA polymerases are active 
under the ionic conditions employed (35% of the 
total nuclear RNA synthesis activity is due to the 
action of polymerase II, as shown using (Y- 
amanitin). 
In order to decide whether the differential 
response of nuclei to the cytosol fractions added is 
due to tissue specificity of the glucocorticoid recep- 
tor or arises from other components within the 
confines of the nucleus, we have extended the 
previous experiments to encompass the effect of 
heterologous cytosol fractions on nuclear tran- 
scription. In these experiments we observed a 
Table 1 
Sequential translocation of thymus and liver glucocorticoid- 
receptor complexes to liver nuclei 
Nuclei in the presence Nuclear translocated 
[3H]dexamethasone 
(dpm/mg DNA) after 
incubation time (min) 
30 60 90 120 
Liver nuclei + thymus DE1 
(step a) 6600 8700 10500 10600 
Liver nuclei of step a after 
transcription assay (step b) 1700 2000 3100 3200 
Liver nuclei of step b + liver 
DE1 (step c) 7900 11800 13800 14800 
Liver nuclei + thymus DE2 
(step a) 2850 4140 5250 6000. 
Liver nuclei of step a after 
transcription assay (step b) 1250 1840 1730 2110 
Liver nuclei of step b + liver 
DE2 (step c) 4800 6000 7100 8000 
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Fig. 1. (a,b) Correlation between nuclear translocation (binding sites per nucleus) of thymus DE-l (a) and DE-2 (b) and RNA synthesis 
in liver nuclei in vitro. Data are represented as % difference of RNA synthesis of DE-fraction-treated vs control nuclei. Each point 
represents the mean value of triplicate assays of three experiments. 
25-30070 inhibitory effect on transcription of these 
heterologous fractions, independent of the source 
of nuclei (figs la,b, 2a,b). The relationship be- 
tween bound glucocorticoid-receptor complex and 
transcriptional activity is linear. To elicit these ef- 
fects on transcription, an activated glucocorticoid- 
receptor complex is necessary, since fractions cor- 
responding to DE-l and DE-2, but obtained from 
cytosol preincubated with the glucocorticoid an- 
tagonist, cortexolone, have no effect on thymus or 
liver nuclear transcription [8]. TAT mRNA is one 
of the mRNA species induced by glucocorticoids in 
target cells. We monitored the amount of TAT 
gene transcripts in liver nuclei after treatment with 
liver and thymus DE fractions and observed (table 
2) a 28% increase in RNA hybridizing with the 
TAT cDNA probe in the presence of liver DE frac- 
tions, whereas in the presence of the thymus frac- 
tions, hybridization was decreased to an approxi- 
mately similar extent. We should add that nuclease 
activity was monitored in these experiments and 
found to be constant and not to be related to the 
observed differences in rates of RNA synthesis. 
The finding that transcription is modulated 
similarly by fractions DE-l and DE-2 can be 
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ascribed to the fact that both of these fractions 
contain glucocorticoid receptor possessing the 
same DNA- and hormone-binding domain and to 
the possible existence of multiple transcription fac- 
tors distributed in the various chromatographic 
fractions obtained. In a further series of ex- 
periments, we investigated whether the observed 
effects on transcription of the various cytosol frac- 
tions are reversible. Liver nuclei were pretreated 
with thymus DE fractions and then incubated 
under conditions of active transcription. This 
resulted in gradual release of the bound receptor 
(table 1). Subsequent addition of liver DE frac- 
Table 2 
Effect of DE fractions on tyrosine aminotransferase gene 
expression in liver nuclei 
Nuclei in the presence of Level of hybridization (W) 
L-DE-l +28 
L-DE-2 + 25 
T-DE- 1 -25 
T-DE-2 -27 
6 pg genomic TAT subclones hybridized with [32P]RNA from 
treated nuclei; 3 yg pBR322 was used as control 
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Fig.2. (a,b) Correlation between nuclear translocation of 
thymus DE-l (a) and DE-2 (b) and RNA synthesis in thymus 
nuclei in vitro. Experimental details as in fig.1. 
tions led to binding of the liver glucocorticoid 
receptor to acceptor sites and to restoration of 
transcriptional activity, either to control levels (in- 
cubation in the presence of DE-2) or to a level of 
approx. 20% over control (incubation with DE-I) 
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Fig.3. (a,b) Effects of liver DE fractions on RNA synthesis of 
liver pretreated with thymus DE fractions. Liver nuclei were 
incubated with thymus DE-l (a) or DE-2 (b) for varoius 
periods, followed by liver DE-l (a) and liver DE-2 (b). 
Translocation of glucocorticoid receptor complex and 
transcriptional activity were measured as described in the text. 
Data are expressed as % difference in RNA synthesis of treated 
vs control nuclei. 
(fig.3a,b). We ascribe the inhibition of transcrip- 
tion observed on addition of liver DE fractions to 
thymus nuclei and of thymus DE fractions to liver 
nuclei, to the presence in thymus nuclei and 
thymus cytosol of tissue-specific factors that can 
affect this process negatively only when acting 
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cooperatively with the glucocorticoid-receptor 
complex. These factors would originally have been 
mainly localized in nuclei, but very probably 
would have entered the cytoplasm during prepara- 
tion. In the absence of such specific inhibitory 
molecules (i.e. in the liver system), the glucocor- 
ticoid receptor, in cooperation with other nuclear 
transcription factors, as shown recently [lo], 
positively regulates gene expression. We are cur- 
rently attempting to isolate such putative tissue- 
specific factors which, in conjunction with the 
glucocorticoid receptor, play a major role in 
glucocorticoid-regulated tissue-specific expression, 
and to explore their interaction with the receptor at 
the level of the gene. 
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